- Home
- APT vs NVNO Comparison
APT vs NVNO Comparison
Compare APT & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- NVNO
- Stock Information
- Founded
- APT 1983
- NVNO 1987
- Country
- APT Canada
- NVNO United States
- Employees
- APT N/A
- NVNO N/A
- Industry
- APT
- NVNO Medical/Dental Instruments
- Sector
- APT
- NVNO Health Care
- Exchange
- APT Nasdaq
- NVNO Nasdaq
- Market Cap
- APT 61.6M
- NVNO 51.7M
- IPO Year
- APT 1995
- NVNO N/A
- Fundamental
- Price
- APT $5.14
- NVNO $2.73
- Analyst Decision
- APT
- NVNO
- Analyst Count
- APT 0
- NVNO 0
- Target Price
- APT N/A
- NVNO N/A
- AVG Volume (30 Days)
- APT 33.4K
- NVNO 137.6K
- Earning Date
- APT 11-06-2024
- NVNO 10-31-2024
- Dividend Yield
- APT N/A
- NVNO N/A
- EPS Growth
- APT 20.88
- NVNO N/A
- EPS
- APT 0.37
- NVNO N/A
- Revenue
- APT $59,288,000.00
- NVNO N/A
- Revenue This Year
- APT N/A
- NVNO N/A
- Revenue Next Year
- APT N/A
- NVNO N/A
- P/E Ratio
- APT $14.17
- NVNO N/A
- Revenue Growth
- APT 1.88
- NVNO N/A
- 52 Week Low
- APT $4.64
- NVNO $2.74
- 52 Week High
- APT $6.92
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- APT 42.27
- NVNO 30.94
- Support Level
- APT $5.06
- NVNO $2.90
- Resistance Level
- APT $5.33
- NVNO $2.93
- Average True Range (ATR)
- APT 0.22
- NVNO 0.16
- MACD
- APT 0.01
- NVNO -0.02
- Stochastic Oscillator
- APT 50.72
- NVNO 5.45
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).